Pluristem Therapeutics Inc. Announces Proposed Public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
25
Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock

HAIFA, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine company developing novel placenta-based cell therapy product candidates, announced today that it intends to offer and sell shares of its common stock and warrants in an underwritten public offering and shares of its common stock in a concurrent registered direct offering. All of the shares and warrants in the underwritten public offering, and the shares in the concurrent registered direct offering, are to be sold by Pluristem. Pluristem intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or warrants offered in the public offering at the public offering price, less the underwriting discounts and commissions.

The Company intends to use the net proceeds of both offerings for research and product development activities, clinical trial activities, investment in capital equipment and for working capital and other general corporate purposes.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE American: LTS), is acting as sole book running manager in connection with the underwritten public offering and as placement agent in the registered direct offering. Both offerings are subject to market and other conditions, and there can be no assurances as to whether or when the offerings may be completed, or as to the actual size or terms of the offerings.

The shares of common stock and warrants offered in the underwritten public offering and the shares of common stock offered in the registered direct offering described above are being offered by Pluristem pursuant to its shelf registration statement on Form S-3 (File No. 333-218916) previously filed and declared effective by the Securities and Exchange Commission (the “SEC”) on June 30, 2017. The offerings may be made only by means of a prospectus supplement and accompanying prospectus.  When available, copies of the preliminary prospectus supplement and the accompanying prospectus relating to the underwritten public offering may be obtained from Ladenburg Thalmann & Co. Inc., Prospectus Department, 277 Park Ave, 26th Floor, New York, NY 10172, by calling (212) 409-2000, or by email at prospectus@ladenburg.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Pluristem Therapeutics

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is conducting late stage clinical trials in several indications. Based on nonclinical research, PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, ischemia, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off-the-shelf, without tissue matching. Pluristem has a strong intellectual property position; Company owned and operated, GMP-certified manufacturing and research facility; strategic relationships with major research institutions; and a seasoned management team.

Safe Harbor Statement

This press release contains expressed or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws. For example, the Company is using forward-looking statements when the Company discusses the expected offerings, the possible offering of additional shares and/or warrants and its intended use of proceeds. These forward-looking statements and their implications are based on the current expectations of the management of the Company only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors and those discussed in the "Risk Factors" section in Pluristem’s most recently filed Annual Report on Form 10-K, as well as other risks detailed in Pluristem's subsequent filings with the Securities and Exchange Commission, among others, could cause actual results to differ materially from those described in the forward-looking statements: market risks and uncertainties, the success of the public offering, use of proceeds of the public offering, and the satisfaction of all conditions to, and the timely closing of, the offering; which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. There can be no assurance that the actual results or developments anticipated by Pluristem will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Pluristem. All information in this press release is as of the date of the release and Pluristem undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events unless required by law.

Contact:

Efrat Kaduri Director of Business, Investor and Public Relations 972-74-7108600 efratk@pluristem.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 146

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
Zoomlion’s Australian Service Push Looks Built to Last

Updated Category News Views 54

Five Australian business centres are one thing; getting a stalled crane or earthmover moving again is the whole ballgame. Zoomlion’s Nov. 4 customer gathering in Sydney matters because Chairman and CEO Zhan Chunxin kept the discussion on the unglamorous stuff: product quality, technical support, parts availability and local training. That is exactly where an equipment...

Continue Reading
Satellite NTN's $3.22B Promise Needs Real Receipts

Updated Category News Views 17

Dead zones over oceans, deserts, and flight paths are finally becoming a serious commercial problem, not merely a neat engineering demo. That is the muscle behind the satellite non-terrestrial network, or NTN, pitch: connect aircraft, vessels, remote assets, and scattered sensors where terrestrial networks simply do not reach. MarketsandMarkets projects this market will...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 135

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
Zoomcar's November 23 Report Puts Execution on Trial

Updated Category News Views 73

A Date on the Board, Not a Verdict November 23 is when Zoomcar finally has to put some fresh numbers beside the story. The Bengaluru-based peer-to-peer car-sharing marketplace says it will release second-quarter fiscal 2027 financial and operating results that Monday, covering the quarter ended September 30, 2026. Management also plans a live webcast at 8:00 a.m. Eastern...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 142

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
LLCP Backs Empower in UK Infrastructure Services Push

Updated Category News Views 144

A majority cheque has landed in a business built around unglamorous work that cannot be wished away: keeping mechanical and electrical systems installed, refurbished and maintained. On November 18, LLCP said it completed a majority investment in London-headquartered Empower Technical Services alongside chief executive Nicholas Manning, co-founders Florian Kronawitter and...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 41

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 95

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Elanco’s $600 Million Buyback Signals a New Chapter

Updated Category News Views 52

Debt coming down and cash coming in finally gave Elanco room to breathe. On Nov. 19, 2026, the animal-health company authorized its first-ever share repurchase program, allowing up to $600 million of common-stock purchases. For NYSE: ELAN, this is more than a flashy capital-return headline. It marks a shift from the ugly but necessary job of balance-sheet repair toward a...

Continue Reading

Top 5 Most Recently Viewed Articles

BRI Expands Financial Services for Indonesian Workers in Taiwan

Updated Category News Views 324

BRI Launches Taipei Branch for Indonesian Migrant Workers PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) has extended its services into Taiwan with the opening of the BRI Taipei Branch. This strategic move aims to serve the needs of approximately 360,000 Indonesian migrant workers residing in the region. A Comprehensive Financial Hub The BRI Taipei Branch is uniquely...

Continue Reading
Middlefield Canadian Income PCC: Latest Asset Value Insights

Updated Category News Views 58

All About Middlefield Canadian Income PCC Middlefield Canadian Income PCC is an important investment option designed to maximize shareholder returns. This protected cell company is licensed and registered in Jersey, with the registration number 93546 and the Legal Entity Identifier 2138007ENW3JEJXC8658. Its primary goal is to provide stable income through a range of...

Continue Reading
Sonoco Products: Key Insights Ahead of Earnings Report

Updated Category News Views 221

Overview of Sonoco Products Sonoco Prods (NYSE:SON) is poised to release its quarterly earnings report soon, attracting the attention of investors eager to learn about the company's financial performance. As earnings season approaches, many stakeholders contemplate the implications for Sonoco's stock. What Analysts Expect Market analysts predict that Sonoco Prods will...

Continue Reading
Marketwise Inc's Rising Short Interest: What It Means

Updated Category News Views 158

Understanding Marketwise Inc's Short Interest Trends Marketwise Inc (NYSE:MKTW) has recently seen a significant increase in its short interest, which has jumped by 52.94% since the last report. Currently, approximately 27 thousand shares are sold short, making up 1.3% of the company's available trading shares. For traders, covering these short positions would take about...

Continue Reading
Unlocking Efficiency: The Evolution of Dayforce AI Agents

Updated Category News Views 92

Dayforce AI Agents: Revolutionizing Workplace Productivity Dayforce, Inc. (NYSE: DAY; TSX: DAY) has recently introduced its latest innovation, the Dayforce AI Agents, aiming to enhance productivity and streamline workflows across organizations. By focusing on automating repetitive tasks, these AI solutions are designed to empower employees, allowing them to concentrate on...

Continue Reading